Natera (NTRA) Reports Q1 Loss, Tops Revenue Estimates

Company Performance - Natera reported a quarterly loss of $0.50 per share, which was better than the Zacks Consensus Estimate of a loss of $0.59, and an improvement from a loss of $0.56 per share a year ago, representing an earnings surprise of 15.25% [1] - The company posted revenues of $501.83 million for the quarter ended March 2025, exceeding the Zacks Consensus Estimate by 13.19%, and showing a significant increase from year-ago revenues of $367.74 million [2] - Natera has surpassed consensus EPS estimates in all four of the last quarters [2] Stock Outlook - The immediate price movement of Natera's stock will largely depend on management's commentary during the earnings call and future earnings expectations [3] - Natera shares have increased by approximately 1.1% since the beginning of the year, contrasting with a decline of -4.3% in the S&P 500 [3] Earnings Estimates - The current consensus EPS estimate for the upcoming quarter is -$0.52 on revenues of $460.85 million, and for the current fiscal year, it is -$2.02 on revenues of $1.92 billion [7] - The estimate revisions trend for Natera is mixed, resulting in a Zacks Rank 3 (Hold), indicating that shares are expected to perform in line with the market in the near future [6] Industry Context - The Medical Services industry, to which Natera belongs, is currently ranked in the top 22% of over 250 Zacks industries, suggesting a favorable outlook compared to lower-ranked industries [8] - Another company in the same industry, IceCure Medical Ltd. (ICCM), is expected to report a quarterly loss of $0.08 per share, with revenues projected at $0.75 million, reflecting a 1.4% increase from the year-ago quarter [9]